Novartis to build 4th radioligand therapy facility in US, expanding $23 B investment

Novartis, a leading global innovative medicines company, has announced plans to build its fourth US radioligand therapy ...

January 13, 2026 | Tuesday | News
Nuvation Bio and Eisai license Taletrectinib rights outside US, China and Japan for $230 M

US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...

January 13, 2026 | Tuesday | News
Taiwan's OBI Pharma inks agreement US-based TegMine Therapeutics for glycan-targeting ADC

Taiwan based OBI Pharma has entered into a commercial license agreement with TegMine Therapeutics, Inc., a San Francisco...

January 13, 2026 | Tuesday | News
Japan's Takeda partners with Halozyme to continue advancing Vedolizumab with ENHANZE® drug-delivery technology

Japanese pharmaceutical firm Takeda has announced a global collaboration and license agreement with US-based Halozyme Th...

January 12, 2026 | Monday | News
China's MediLink signs additional exclusive licensing deal with Roche for $570 M

China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...

January 12, 2026 | Monday | News
Revvity collaborates with Eli Lilly to expand access to AI drug discovery models

US-based Revvity, Inc. has announced a collaboration with Eli Lilly and Company (Lilly) that expands acce...

January 12, 2026 | Monday | News
SK bioscience and Sanofi launch MenQuadfi meningococcal vaccine in Korea

SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent menin...

January 12, 2026 | Monday | News
Santhera licenses AGAMREE to Japan's Nxera Pharma in $205 M Asia-Pacific deal

Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...

January 9, 2026 | Friday | News
Taiwan's Foresee Pharma inks $584.5M deal with Primevera Therapeutics

Taiwan-based Foresee Pharmaceuticals has announced that Foresee Pharmaceuticals USA Inc., the company's fully-owned US s...

January 9, 2026 | Friday | News
Korea's Sky Labs secures European approval for ring-type blood pressure monitor

South Korea based startup Sky Labs has announced that its ring-type blood pressure monitor, 'CART PLATFORM,' recent...

January 9, 2026 | Friday | News
Ribo Life Science successfully lists on Main Board of Hong Kong Stock Exchange

Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...

January 9, 2026 | Friday | News
Kyorin and Lunatus partner to launch Lasvic tablets in nine Middle Eastern countries

Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulti...

January 8, 2026 | Thursday | News
Xellar, Woojung Bio to advance AI-enabled organ-on-a-chip preclinical models

US-based startup Xellar Biosystems, a globally leading innovator in next-generation artificial intelligence (AI)- a...

January 8, 2026 | Thursday | News
Sanofi announces sales transfer of anticancer agent JEVTANA to Taiho in Japan

Sanofi K.K. and Taiho Pharmaceutical have announced that the sales of the anticancer agent Jevtana® I.V. Infusion 60...

January 6, 2026 | Tuesday | News
Singapore's Hyphens Pharma out-licences Cerapro® MED to six European countries

Singapore-based Hyphens Pharma International has granted the rights to commercialise its innovative product, Cerapro®...

January 5, 2026 | Monday | News
Insilico Medicine announces $888 M multi-year collaboration with Servier for drug discovery in oncology

Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...

January 5, 2026 | Monday | News
Taiwan's ScinoPharm secures US FDA approval of Glatiramer Acetate Injection for MS treatment

ScinoPharm Taiwan has announced a landmark achievement in the global pharmaceutical landscape, securing US Food and Drug...

January 5, 2026 | Monday | News
Shionogi expands rare disease presence with acquisition of global rights to Tanabe's RADICAVA for $2.5 B

Japan's Shionogi & Co. will acquire a newly established company that Tanabe Pharma Corporation will create to hold t...

January 2, 2026 | Friday | News
Insilico Medicine lists on Hong Kong Stock Exchange, showing largest Hong Kong biotech IPO

Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...

January 2, 2026 | Friday | News
Mabwell's Adalimumab Biosimilar receives marketing approval in Indonesia

China-based Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announce...

January 2, 2026 | Friday | News
Korean startup KLMBio accelerates global expansion in bone graft market

South Korea-based KLMBio, a manufacturer and exporter of human tissue-based medical devices, is accelerating its global ...

January 2, 2026 | Friday | News
“There are talent shortages in specialised modalities such as ADCs, peptides, and computational biology”

How would KBI Biopharma highlight its achievements in 2025? Which key projects strengthened the company’s global C...

January 3, 2026 | Saturday | Opinion
Momentum in Motion: What Will Shape APAC's Life Sciences Landscape in 2026?

Asia-Pacific’s life sciences landscape has always been shaped by contrasts. It is a region where scale and sophist...

January 3, 2026 | Saturday | Opinion
Lupin signs agreement with Gan & Lee Pharma for novel GLP-1 receptor agonist

Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...

December 29, 2025 | Monday | News
Fujifilm announces opening of one of Japan's largest Bio CDMO facilities

Fujifilm Corporation has announced the completion of one of Japan’s largest bio CDMO facilities (the new plan...

December 26, 2025 | Friday | News